Fig. 1
From: Sintilimab for the treatment of non-small cell lung cancer
Timeline of clinical trials and approvals of sintilimab on non-small cell lung cancer. Dates indicate the time when the data of the research were first available online. FIH, first-in-human study; GGN, ground-glass nodule; PP, platinum plus pemetrexed; GP, platinum plus gemcitabine; NSCLC, non-small cell lung cancer; CIK, cytokine-induced killer cell immunotherapy